62 results  1 of 4 

1 Thyroid Cancer, Iodine, and Gene Mutation
Jae Hoon Chung
Int J Thyroidol.2023;16(1):89-95.   Published online 2023 May 30     DOI: http://dx.doi.org/10.11106/ijt.2023.16.1.89
      
2 Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea
Sunhee Chang, Yoon-La Choi, Hyo Sup Shim, Geon Kook Lee, Seung Yeon Ha
J Pathol Transl Med.2022;56(6):334-341.   Published online 2022 October 27     DOI: http://dx.doi.org/10.4132/jptm.2022.08.22
      
3 Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer
Chae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol Ahn
Int J Thyroidol.2021;14(2):127-134.   Published online 2021 November 30     DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.127
      
4 Null Association between BRAF V600E Mutation and Tumor Recurrence in Patients with Papillary Thyroid Microcarcinoma in South Korea
Ji Yoon Kim, Kyoung Jin Kim, Jae Hyun Bae, Joo Hyung Kim, Nam Hoon Kim, Hee Young Kim, Hoon Yub Kim, Seung-Kuk Baek, Sin Gon Kim, Kwang Yoon Jung, Kyeong Jin Kim
Int J Thyroidol.2021;14(2):135-142.   Published online 2021 November 30     DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.135
      
5 Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma
Inwoo Hwang, Yoon-La Choi, Hyunwoo Lee, Soohyun Hwang, Boram Lee, Hobin Yang, Chaithanya Chelakkot, Joungho Han
Cancer Res Treat.2022;54(3):782-792.   Published online 2021 November 23     DOI: http://dx.doi.org/10.4143/crt.2021.843
      
6 Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
Kyoung Sik Park, Madhuri Saindane, Eun Yeol Yang, TongYi Jin, Harikrishna Reddy Rallabandi, Alexander Heil, Sang Eun Nam, Young Bum Yoo, Jung-Hyun Yang, Jong Bin Kim, Seo-Young Park, Won Seo Park, Yeo-Kyu Youn
Ann Surg Treat Res.2021;100(3):127-136.   Published online 2021 February 26     DOI: http://dx.doi.org/10.4174/astr.2021.100.3.127
      
7 Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
Eun Jeong Ban, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Kunhong Kim
Endocrinol Metab.2021;36(1):96-105.   Published online 2021 February 24     DOI: http://dx.doi.org/10.3803/EnM.2020.819
      
8 New Molecular Targeted Therapy of Metastatic Colorectal Cancer
Jungmin Jo
Ewha Med J.2021;44(1):11-18.   Published online 2021 January 31     DOI: http://dx.doi.org/10.12771/emj.2021.44.1.11
      
9 A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
Thu Dang Anh Phan, Bao Gia Phung, Tu Thanh Duong, Vu Anh Hoang, Dat Quoc Ngo, Nguyen Dinh The Trinh, Tung Thanh Tran
J Pathol Transl Med.2021;55(2):112-117.   Published online 2021 January 27     DOI: http://dx.doi.org/10.4132/jptm.2020.11.30
      
10 KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute
Yonggoo Kim, Sung-Soo Park, Chang-Ki Min, Gun Dong Lee, Jungok Son, Sung Jin Jo, Eunhee Han, Kyungja Han, Myungshin Kim
Blood Res.2020;55(3):159-168.   Published online 2020 September 30     DOI: http://dx.doi.org/10.5045/br.2020.2020137
      
11 Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
Young Shin Song, Young Joo Park
Endocrinol Metab.2020;35(3):515-525.   Published online 2020 September 22     DOI: http://dx.doi.org/10.3803/EnM.2020.304
      
12 Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell Histiocytosis
Ying Yang, Dong Wang, Lei Cui, Hong-Hao Ma, Li Zhang, Hong-Yun Lian, Qing Zhang, Xiao-Xi Zhao, Li-Ping Zhang, Yun-Ze Zhao, Na Li, Tian-You Wang, Zhi-Gang Li, Rui Zhang
Cancer Res Treat.2021;53(1):261-269.   Published online 2020 September 15     DOI: http://dx.doi.org/10.4143/crt.2020.769
      
13 Expressions of miRNAs in Papillary Thyroid Carcinoma and Their Associations with the BRAFV600E Mutation and Clinicopathological Features
Song I Yang, Young Sik Choi
Kosin Med J.2020;35(1):1-14.   Published online 2020 June 30     DOI: http://dx.doi.org/10.7180/kmj.2020.35.1.1
      
14 Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung
J Pathol Transl Med.2020;54(4):310-317.   Published online 2020 June 15     DOI: http://dx.doi.org/10.4132/jptm.2020.05.12
      
15 Efficacy of Annexin A1 Immunostaining in Bone Marrow for the Diagnosis of Hairy Cell Leukemia
Chang-Hun Park, Hyun-Young Kim, Sang-Yong Shin, Hee-Jin Kim, Chul Won Jung, Jong-Won Kim, Sun-Hee Kim
Lab Med Online.2019;9(4):236-241.   Published online 2019 October 1     DOI: http://dx.doi.org/10.3343/lmo.2019.9.4.236
      
16 Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells
Mi-Hyeon You, Min Ji Jeon, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Won Gu Kim
Endocrinol Metab.2019;34(2):203-212.   Published online 2019 June 24     DOI: http://dx.doi.org/10.3803/EnM.2019.34.2.203
      
17 Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer
Maria Sfakianaki, Chara Papadaki, Maria Tzardi, Maria Trypaki, Sardar Alam, Eleni D. Lagoudaki, Ippokratis Messaritakis, Odysseas Zoras, Dimitris Mavroudis, Vassilis Georgoulias, John Souglakos
Cancer Res Treat.2019;51(4):1518-1526.   Published online 2019 March 20     DOI: http://dx.doi.org/10.4143/crt.2019.008
      
18 Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
Cancer Res Treat.2019;51(4):1392-1399.   Published online 2019 February 20     DOI: http://dx.doi.org/10.4143/crt.2018.612
      
19 Relation between RASSF1A Methylation and BRAF Mutation in Thyroid Tumor
Kyoung Ho Oh, Kwang Yoon Jung, Seung Kuk Baek, Jeong Soo Woo, Jae Gu Cho, Soon Young Kwon
Int J Thyroidol.2018;11(2):123-129.   Published online 2018 November 30     DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.123
      
20 Expression of Sodium-Iodide Symporter Depending on Mutational Status and Lymphocytic Thyroiditis in Papillary Thyroid Carcinoma
Young Shin Song, Young Joo Park
Int J Thyroidol.2018;11(2):152-159.   Published online 2018 November 30     DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.152
      

 1 of 4